O discurso do risco na controvérsia dos emagrecedores: uma análise da cobertura de imprensa nos anos de 2011 e 2014

Amaral, Vanessa Melo do; Laguardia, Josué; Cardoso, Janine Miranda.
RECIIS (Online) ; 11(3): 1-19, jul.-set.2017.
Artigo em Português | ENSP, FIOCRUZ | ID: ens-36031

Documentos relacionados

  1. Anorectic effect of COR659 in a rat model of overeating.
  2. Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells.
  3. Iodination of CART(61-102) peptide: Preserved binding and anorexigenic activity in mice.
  4. Person-centered choice of anti-obesity pharmacotherapy.
  5. Phentermine: A Systematic Review for Plastic and Reconstructive Surgeons.
  6. The unidentified hormonal defense against weight gain.
  7. Pharmacotherapy of obesity: An update.
  8. Three- and six-month efficacy and safety of phentermine in a Mexican obese population.
  9. The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization.
  10. Análise dos efeitos adversos associados ao uso do anorexígeno sibutramina: revisão sistemática